| # | Drug | Count |
|---|---|---|
| 0 | SOMATROPIN | 8152 |
| 1 | INSULIN GLARGINE | 1078 |
| 2 | ALBUTEROL SULFATE | 742 |
| 3 | ALBUTEROL | 500 |
| 4 | INSULIN GLARGINE-YFGN | 322 |
| 5 | METFORMIN | 216 |
| 6 | METFORMIN ER 500 MG | 209 |
| 7 | METFORMIN ER 750 MG | 209 |
| 8 | ETANERCEPT | 198 |
| 9 | FLUTICASONE PROPIONATE AND SALMETEROL | 177 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SOMATROPIN | 8152 | 0.1089 |
| 1 | ADALIMUMAB-AFZB | 122 | 0.0455 |
| 2 | ADALIMUMAB-ADBM | 8 | 0.0299 |
| 3 | SOMATROGON-GHLA | 36 | 0.0289 |
| 4 | PEGFILGRASTIM-JMDB | 8 | 0.0177 |
| 5 | INSULIN GLARGINE-YFGN | 322 | 0.0144 |
| 6 | FILGRASTIM-AAFI | 8 | 0.0120 |
| 7 | OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE | 20 | 0.0098 |
| 8 | GOLIMUMAB | 112 | 0.0089 |
| 9 | INSULIN GLARGINE AND LIXISENATIDE | 29 | 0.0079 |
| # | Drug class | Count |
|---|---|---|
| 0 | Insulin Analog [EPC] | 1293 |
| 1 | Recombinant Human Growth Hormone [EPC] | 602 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 412 |
| 3 | GLP-1 Receptor Agonist [EPC] | 302 |
| 4 | Corticosteroid [EPC] | 219 |
| 5 | Interleukin-23 Antagonist [EPC] | 163 |
| 6 | Copper-containing Intrauterine Device [EPC] | 120 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 108 |
| 8 | Leukocyte Growth Factor [EPC] | 101 |
| 9 | Interleukin-17A Antagonist [EPC] | 76 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Recombinant Human Growth Hormone [EPC] | 602 | 0.0274 |
| 1 | Insulin Analog [EPC] | 1293 | 0.0029 |
| 2 | Copper-containing Intrauterine Device [EPC] | 120 | 0.0024 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 5 | 0.0024 |
| 4 | Parathyroid Hormone-Related Peptide Analog [EPC] | 66 | 0.0021 |
| 5 | Interleukin-17A Antagonist [EPC] | 76 | 0.0020 |
| 6 | Provitamin D2 Compound [EPC] | 47 | 0.0016 |
| 7 | Interleukin-23 Antagonist [EPC] | 163 | 0.0016 |
| 8 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 9 | Thymic Stromal Lymphopoietin Blocker [EPC] | 8 | 0.0012 |